Drugs / ALC-919
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02483455 | Apr → Oct 2015 | common wart | Veloce BioPharma LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ALC-919 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02483455 ↗ |
| Route | Topical | “ALC-919 Topical Solution will be applied twice daily to study area” NCT02483455 ↗ |